Hailey Joyce Miller, | |
1926 Briarwood St, Louisville, OH 44641-9103 | |
(330) 495-1593 | |
Not Available |
Full Name | Hailey Joyce Miller |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 1926 Briarwood St, Louisville, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700639143 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Hailey Joyce Miller, 1926 Briarwood St, Louisville, OH 44641-9103 Ph: (330) 495-1593 | Hailey Joyce Miller, 1926 Briarwood St, Louisville, OH 44641-9103 Ph: (330) 495-1593 |
News Archive
Valley fever is endemic to hot and dry regions such as the southwestern United States and California's San Joaquin Valley, but scientists at the University of California, Irvine predict that climate change will cause the fungal infection's range to more than double in size this century, reaching previously unaffected areas across the western U.S.
Leading breast cancer organizations Susan G. Komen for the CureĀ® and the Canadian Breast Cancer Foundation in Canada today announce a new agreement to raise funds and explore possibilities to partner in research, education, advocacy and awareness programs across borders.
WageWorks, Inc., a leader in administering Consumer-Directed Benefits, today announced a partnership with Summit Health, a leading provider of on-site wellness, health screening and immunization programs. In this partnership, WageWorks will offer Summit Health's wellness services to its clients. Additionally, Summit Health clients will have access to WageWorks' Health Savings Accounts (HSAs) and Health Reimbursement Arrangements (HRAs).
Scientists have shed new light on how the common painkiller paracetamol causes liver damage.
Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.
› Verified 7 days ago